Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LSM14B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | PABPC5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | MAGEA4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | ZNF232 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | PERM1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | PHLPP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | H1FX | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | CLSTN2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | AMER3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | TMEM94 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |